Jonathan J Cherry Selected Research

2,4-diaminoquinazoline

1/2017	In vitro and in vivo effects of 2,4 diaminoquinazoline inhibitors of the decapping scavenger enzyme DcpS: Context-specific modulation of SMN transcript levels.
1/2017	Design of Potent mRNA Decapping Scavenger Enzyme (DcpS) Inhibitors with Improved Physicochemical Properties To Investigate the Mechanism of Therapeutic Benefit in Spinal Muscular Atrophy (SMA).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jonathan J Cherry Research Topics

Disease

6	Spinal Muscular Atrophy (Progressive Muscular Atrophy) 01/2017 - 09/2011
1	Friedreich Ataxia (Friedreich's Ataxia) 11/2021
1	Carcinogenesis 01/2013
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2013
1	Papillomavirus Infections 01/2013
1	Neurodegenerative Diseases (Neurodegenerative Disease) 12/2007

Drug/Important Bio-Agent (IBA)

5	Proteins (Proteins, Gene)FDA Link 01/2017 - 09/2011
2	EnzymesIBA 01/2017 - 01/2017
2	2,4-diaminoquinazolineIBA 01/2017 - 01/2017
2	Pharmaceutical PreparationsIBA 08/2014 - 07/2013
1	FrataxinIBA 11/2021
1	Messenger RNA (mRNA)IBA 01/2017
1	DAQIBA 01/2017
1	5- ((1- (2,6- dichlorobenzyl)piperidin- 4- yl)methoxy)quinazoline- 2,4- diamineIBA 01/2017
1	Antiviral Agents (Antivirals)IBA 01/2013

Therapy/Procedure

2	Therapeutics 01/2013 - 12/2007